Physician profile
Shyam Bhaskar
NPI 1194788158
$6,199.62
in general payments reported to CMS, 2019-2025
46 companies · $877 in 2025
The $877 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $822 · 2021: $956 · 2022: $1,186 · 2023: $1,005 · 2024: $532 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.51 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,047.59 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $821.11 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Novo Nordisk INC | $810.27 | 2019-2024 | Ozempic, Rybelsus, Tresiba |
| Boehringer Ingelheim Pharmaceuticals, INC. | $499.26 | 2019-2025 | Jardiance, Ofev |
| Amgen INC. | $303.62 | 2019-2024 | Repatha, Otezla |
| Pfizer INC. | $238.66 | 2019-2025 | |
| Abbvie INC. | $222.95 | 2021-2025 | Vraylar |
| Glaxosmithkline, LLC. | $195.82 | 2024-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $186.17 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $129.39 | 2022 | |
| Mylan Specialty L.P. | $111.79 | 2019-2022 | |
| Becton, Dickinson and Company | $109.44 | 2020-2021 | |
| Amarin Pharma, INC. | $103.24 | 2019-2021 | |
| Dexcom, INC. | $88.09 | 2021-2025 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $76.74 | 2024-2025 | Dupixent |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shyam Bhaskar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.